期刊文献+

非清髓性异基因造血干细胞移植治疗恶性肿瘤 被引量:2

原文传递
导出
摘要 非清髓性异基因造血干细胞移植 ,主要是通过移植物抗肿瘤效应来根除恶性肿瘤细胞 ,与经典的清髓性异基因造血干细胞移植相比 ,其移植相关并发症和病死率降低 ,对年龄较大。
作者 费菲 陈宝安
出处 《国际肿瘤学杂志》 CAS 2005年第1期71-74,共4页 Journal of International Oncology
  • 相关文献

参考文献21

  • 1Renga M,Pedrazzoli P,Siena S.Present results and perspectives of allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of human solid tumors. Annals of Oncology . 2003 被引量:1
  • 2Storb RF,Champlin R,Riddell SR,et al.Non-myeloablative transplants for malignant disease. Hematology . 2001 被引量:1
  • 3Champlin R,Khouri I,Anderlini P,et al.Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation Biology and current indications. Oncology Hunting . 2003 被引量:1
  • 4Appelbaum FR,Sandmaier B.Sensitivity of renal cell cancer to nonmyeloablative allogeneic hematopoietic cell transplantations: unusual or unsually Important. Journal of Clinical Oncology . 2002 被引量:1
  • 5Appelbaum FR.Haematopoietic cell transplantation as immunotherapy. Nature . 2001 被引量:1
  • 6Storb RF,Lucarelli G,McSweeney PA,et al.Hematopoietic cell transplantation for benign hematological disorders and solid tumors. Hematology . 2003 被引量:1
  • 7Mielcarek M,Martin PJ,Leisenring W,et al.Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood . 2003 被引量:1
  • 8Riddell SR,Murata M,Bryant S,et al.Minor histocompatibility antigens-targets of graft versus leukemia responses. International Journal of Hematology . 2002 被引量:1
  • 9Tabbara IA,Ingram RM.Nonmyeloablative therapy and allogeneic hematopoietic stem cell transplantation. Experimental Hematology . 2003 被引量:1
  • 10Childs RW.Immunotherapy of solid tumors: nonmyeloablative allogeneic stem cell transplantation. Medscape General Medicine . 2002 被引量:1

同被引文献24

  • 1刘丽辉,艾辉胜.HLA半相合造血干细胞移植进展[J].国外医学(移植与血液净化分册),2004,2(4):27-30. 被引量:6
  • 2胡晶,吴宏.造血干/祖细胞归巢的研究进展[J].国外医学(内科学分册),2005,32(5):195-199. 被引量:3
  • 3Chut JP.Stem cell homing.Curr Opin Hematol,2006;13(6):399-406. 被引量:1
  • 4Storb RF,Champlin R,Riddell SR,et al.Non-myeloablativetransplants for malignant disease.Hematology Am Soc HematolEduc Program,2001;375-391. 被引量:1
  • 5Salem ML,Al-Khami AA,El-Naggar SA,et al.Cyclopho-sphamide induces dynamic alterations in the host microenvironmentsresulting in a Flt3 ligand-dependent expansion of dendritic cells.JImmunol,2010;184(4):1737-1747. 被引量:1
  • 6Kohno A, Morishita Y, Lida H, et al. Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission: a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group. Int J Hematol 2008; 87(2):210-216 被引量:1
  • 7Lu DP, Dong L, Wu T, et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation.Blood 2006; 107:3065-3073 被引量:1
  • 8Bierings M, Nachman JB, Zwaan CM. Stem cell transplantation in pediatric leukemia and myelodysplasia: state of the art and current challenges. Curr Stem Cell Res Ther 2007;2(1):53-63 被引量:1
  • 9Kater AP, van Oers MH, Kipps TJ. Cellular immune therapy for chronic lymphocytic leukemia. Blood 2007; 110(8):2811-2818 被引量:1
  • 10Ogawa H, Ikegame K, Kaida K, et al. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis. Exp Hematol 2008;36(1): 1-8 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部